Proto-oncogene MET (c-met) amplification in human gliomas causes increased activity of its downstream targets (e.g., Wnt/β-catenin signaling) (Moon et al., 2000; Kim et al., 2013), and prolongs the cancer survival (Halatsch et al., 2006). The gene discussed is MET; the disease is cancer.